Will Roche Spin Genentech Off Again?
Does Roche’s recent acquisition of Genentech mean the end of the big-biotech business model? Has Genentech lost it’s independence? Not […]
General Biotechnology
Roche
General Biotechnology
Amgen’s patents protect Epogen. Again.
Amgen’s got a record of savvy patenting to protect their blockbusters, and they’ve just done it again. A U.S. Federal
General Biotechnology
Amgen's patents protect Epogen. Again.
Amgen’s got a record of savvy patenting to protect their blockbusters, and they’ve just done it again. A U.S. Federal